267 related articles for article (PubMed ID: 18435932)
21. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa.
Castagliuolo I; Riegler MF; Valenick L; LaMont JT; Pothoulakis C
Infect Immun; 1999 Jan; 67(1):302-7. PubMed ID: 9864230
[TBL] [Abstract][Full Text] [Related]
22. Rho protein inactivation induced apoptosis of cultured human endothelial cells.
Hippenstiel S; Schmeck B; N'Guessan PD; Seybold J; Krüll M; Preissner K; Eichel-Streiber CV; Suttorp N
Am J Physiol Lung Cell Mol Physiol; 2002 Oct; 283(4):L830-8. PubMed ID: 12225960
[TBL] [Abstract][Full Text] [Related]
23. R-Ras glucosylation and transient RhoA activation determine the cytopathic effect produced by toxin B variants from toxin A-negative strains of Clostridium difficile.
Chaves-Olarte E; Freer E; Parra A; Guzmán-Verri C; Moreno E; Thelestam M
J Biol Chem; 2003 Mar; 278(10):7956-63. PubMed ID: 12496290
[TBL] [Abstract][Full Text] [Related]
24. Glucosylation of Rho proteins by Clostridium difficile toxin B.
Just I; Selzer J; Wilm M; von Eichel-Streiber C; Mann M; Aktories K
Nature; 1995 Jun; 375(6531):500-3. PubMed ID: 7777059
[TBL] [Abstract][Full Text] [Related]
25. Development of a non-radiolabeled glucosyltransferase activity assay for C. difficile toxin A and B using ultra performance liquid chromatography.
Loughney JW; Lancaster C; Price CE; Hoang VM; Ha S; Rustandi RR
J Chromatogr A; 2017 May; 1498():169-175. PubMed ID: 28238427
[TBL] [Abstract][Full Text] [Related]
26. Involvement of Ras-related Rho proteins in the mechanisms of action of Clostridium difficile toxin A and toxin B.
Dillon ST; Rubin EJ; Yakubovich M; Pothoulakis C; LaMont JT; Feig LA; Gilbert RJ
Infect Immun; 1995 Apr; 63(4):1421-6. PubMed ID: 7890404
[TBL] [Abstract][Full Text] [Related]
27. Cellular stability of Rho-GTPases glucosylated by Clostridium difficile toxin B.
Genth H; Huelsenbeck J; Hartmann B; Hofmann F; Just I; Gerhard R
FEBS Lett; 2006 Jun; 580(14):3565-9. PubMed ID: 16730714
[TBL] [Abstract][Full Text] [Related]
28. Autocatalytic processing of Clostridium difficile toxin B. Binding of inositol hexakisphosphate.
Egerer M; Giesemann T; Herrmann C; Aktories K
J Biol Chem; 2009 Feb; 284(6):3389-95. PubMed ID: 19047051
[TBL] [Abstract][Full Text] [Related]
29. Cholesterol-dependent pore formation of Clostridium difficile toxin A.
Giesemann T; Jank T; Gerhard R; Maier E; Just I; Benz R; Aktories K
J Biol Chem; 2006 Apr; 281(16):10808-15. PubMed ID: 16513641
[TBL] [Abstract][Full Text] [Related]
30. Structure and mode of action of clostridial glucosylating toxins: the ABCD model.
Jank T; Aktories K
Trends Microbiol; 2008 May; 16(5):222-9. PubMed ID: 18394902
[TBL] [Abstract][Full Text] [Related]
31. Auto-catalytic cleavage of Clostridium difficile toxins A and B depends on cysteine protease activity.
Egerer M; Giesemann T; Jank T; Satchell KJ; Aktories K
J Biol Chem; 2007 Aug; 282(35):25314-21. PubMed ID: 17591770
[TBL] [Abstract][Full Text] [Related]
32. Clostridium difficile Toxin Biology.
Aktories K; Schwan C; Jank T
Annu Rev Microbiol; 2017 Sep; 71():281-307. PubMed ID: 28657883
[TBL] [Abstract][Full Text] [Related]
33. The American Cockroach Peptide Periplanetasin-2 Blocks
Hong J; Zhang P; Yoon IN; Hwang JS; Kang JK; Kim H
J Microbiol Biotechnol; 2017 Apr; 27(4):694-700. PubMed ID: 28173695
[No Abstract] [Full Text] [Related]
34. Inactivation of Ras by Clostridium sordellii lethal toxin-catalyzed glucosylation.
Just I; Selzer J; Hofmann F; Green GA; Aktories K
J Biol Chem; 1996 Apr; 271(17):10149-53. PubMed ID: 8626575
[TBL] [Abstract][Full Text] [Related]
35. The Role of Rho GTPases in Toxicity of Clostridium difficile Toxins.
Chen S; Sun C; Wang H; Wang J
Toxins (Basel); 2015 Dec; 7(12):5254-67. PubMed ID: 26633511
[TBL] [Abstract][Full Text] [Related]
36. Change of the donor substrate specificity of Clostridium difficile toxin B by site-directed mutagenesis.
Jank T; Reinert DJ; Giesemann T; Schulz GE; Aktories K
J Biol Chem; 2005 Nov; 280(45):37833-8. PubMed ID: 16157585
[TBL] [Abstract][Full Text] [Related]
37. Effects of Clostridium difficile toxins on epithelial cell barrier.
Pothoulakis C
Ann N Y Acad Sci; 2000; 915():347-56. PubMed ID: 11193598
[TBL] [Abstract][Full Text] [Related]
38. Enteric glial cells are susceptible to Clostridium difficile toxin B.
Fettucciari K; Ponsini P; Gioè D; Macchioni L; Palumbo C; Antonelli E; Coaccioli S; Villanacci V; Corazzi L; Marconi P; Bassotti G
Cell Mol Life Sci; 2017 Apr; 74(8):1527-1551. PubMed ID: 27891552
[TBL] [Abstract][Full Text] [Related]
39. Fidaxomicin and OP-1118 Inhibit Clostridium difficile Toxin A- and B-Mediated Inflammatory Responses via Inhibition of NF-κB Activity.
Koon HW; Wang J; Mussatto CC; Ortiz C; Lee EC; Tran DH; Chen X; Kelly CP; Pothoulakis C
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038278
[No Abstract] [Full Text] [Related]
40. Binding and neutralization of C. difficile toxins A and B by purified clinoptilolite-tuff.
Ranftler C; Nagl D; Sparer A; Röhrich A; Freissmuth M; El-Kasaby A; Nasrollahi Shirazi S; Koban F; Tschegg C; Nizet S
PLoS One; 2021; 16(5):e0252211. PubMed ID: 34043688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
